两性霉素B
PLGA公司
纳米颗粒
纳米技术
裂褶菌公社
溶解
材料科学
医学
抗真菌
化学
皮肤病科
有机化学
生物化学
作者
Ke Peng,Aiman Abu Ammar,Achmad Himawan,Xianbing Dai,Ross Duncan,Brendan Gilmore,Ryan F. Donnelly,Lalitkumar K. Vora
标识
DOI:10.1016/j.jddst.2025.106697
摘要
Cutaneous fungal infections pose a significant health challenge, particularly in deeper skin layers where topical treatments are ineffective. Amphotericin B (AmB) is the gold standard for treating fungal infections, but its poor solubility limits its transdermal delivery. In this work, AmB was loaded into polylactic-co-glycolic acid nanoparticles (PLGA NP) via the solvent deposition method. The resulting NP had an average size of 311.54 ± 2.08 nm and a polydispersity index (PDI) of 0.22 ± 0.12. After reconstitution, the particle size decreased to 209.89 ± 1.10 nm, with a PDI of 0.10. The encapsulation efficiency was 98.59 ± 0.10%. These AmB-loaded PLGA NP were then incorporated into dissolving microneedles (MNs) using a sequential loading method. The MNs demonstrated adequate mechanical strength to deliver the NP into the deep dermal layers, with an insertion depth of 363.5 μm and a height reduction of only 3.56 ± 2.10% under compression. In vitro release studies revealed an initial burst release of 60% within 1 h, followed by a slower release over four days. Ex vivo skin deposition and permeation studies demonstrated remarkable deposition of the drug into the dermis skin layers. This delivery system offers significant potential for treating cutaneous fungal infections, combining the benefits of sustained drug release and targeted delivery to deep skin layers.
科研通智能强力驱动
Strongly Powered by AbleSci AI